Search
for
Sort by
Research 601–630 of 1000+
- Relationship of Serum Prostate Specific Antigen with Hirsutism in Women Having Polycystic Ovary Syndrome Belonging to the Province of Khyber Pakhtunkhwa, Pakistan
- Pharmakokinetik und Biokonversion von Dehydroepiandrosteron nach Dexamethason-Vorbehandlung bei Frauen mit dem Syndrom der polyzystischen Ovarien
- Polycystic ovary syndrome and the differential diagnosis of hyperandrogenism
- Period problems: disorders of menstruation in adolescents
- Disorders of ovulation
- Men??s Health
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
- The effect of metformin on hirsutism in polycystic ovary syndrome
- Cardiometabolic profile of young women with hypoprolactinemia
- Revisiting hyper- and hypo-androgenism by tandem mass spectrometry
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection
- Chapter 17. Selective androgen receptor modulators (SARMs)
- Drug safety evaluation of exemestane
- Hyperadrenocorticism in Ferrets
- Clomiphene Citrate versus Letrozole for Ovulation Induction in PCOS: A Comparative Study
- Managing the PCOS-Related Symptoms of Hirsutism, Acne, and Hair Loss
- A New Immune-Biochemical Study To Identify Indicators Of The Response Of Infertile Polycystic Ovary Syndrome Patients To Metformin Treatment
- Polycystic Ovarian Syndrome - What is New
- Evaluación endocrinológica en el acné
- Definition criteria and diagnostic assessments
- Update on medical management of benign prostatic hyperplasia
- Polycystic Ovarian Syndrome: The Androgenized Adolescent
- Androgen excess is the key element in polycystic ovary syndrome
- Chrousos syndrome: from molecular pathogenesis to therapeutic management
- Male fertility and skin diseases
- A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol
- Virilism and Ectopic Expression of HSD17B5 in Mature Cystic Teratoma
- Prematüre Pubarş Olgularının Değerlendirilmesi: Tek Merkez Deneyimi